Scripps Research Logo

Michael Kosty, M.D.

Professor Adjunct
Department of Molecular Medicine
California Campus
Scripps VIVO Scientific Profile
mkosty@scripps.edu
(858) 784-7197

Education

M.D., The George Washington University, School of Medicine and Health Sciences 1979
M.S. (Biophysics), University of California, Berkeley 1975
Cornell University 1973
B.S. (Engineering Physics), University of California, Berkeley 1972

Professional Experience

2014-2017 Professor Adjunct, Cell and Molecular Biology (CMB), The Scripps Research Institute

Selected References

All Publications

Shenoy, C. S. & Kosty, M. P. Checkpoint inhibitors in advanced lung cancer. (2017). Translational Cancer Research, 6(1), 56-67.

Dittrich, C., Kosty, M. P., Jezdic, S., Pyle, D., Berardi, R., Bergh, J., El-Saghir, N. S., Lotz, J. P., Osterlund, P., Pavlidis, N. & Purkalne, G. Global Curriculum Edition 2016: European society for medical oncology/American society of clinical oncology recommendations for training in medical oncology. (2017). Journal of Clinical Oncology, 35(2), 254-255.

Gordon, R. T., Schatz, C. B., Myers, L. J., Kosty, M., Gonczy, C., Kroener, J., Tran, M., Kurtzhals, P., Heath, S., Koziol, J. A., Arthur, N., Gabriel, M., et al. The use of canines in the detection of human cancers. (2008). Journal of Alternative and Complementary Medicine, 14(1), 61-67.

Meisenberg, B. R., Miller, W. E., McMillan, R., Callaghan, M., Sloan, C., Brehm, T., Kosty, M. P., Kroener, J., Longmire, R., Saven, A. & Piro, L. D. Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. (1997). Journal of Clinical Oncology, 15(1), 11-17.

Beutler, E., Gelbart, T., West, C., Lee, P., Adams, M., Blackstone, R., Pockros, P., Kosty, M., Venditti, C. P., Phatak, P. D., Seese, N. K., Chorney, K. A., et al. Mutation analysis in hereditary hemochromatosis. (1996). Blood Cells Molecules and Diseases, 22(16), 187-194.

Saven, A., Emanuele, S., Kosty, M., Koziol, J., Ellison, D. & Piro, L. 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma. (1995). Blood, 86(5), 1710-1716.

Kosty, M. P., Hench, P. K., Tani, P. & McMillan, R. Thrombocytopenia associated with auranofin therapy - evidence for a gold-dependent immunological mechanism. (1989). American Journal of Hematology, 30(4), 236-239.